CoChat

Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer

Open access

The DOI matches its Crossref record; 53 of the 53 references it cites were found in a registry or an index.

Abstract

INTRODUCTION: Treatments for young patients with gastric cancer (GC) remain poorly defined, and their effects on survival are uncertain. We aimed to investigate the receipt of chemotherapy by age category (18-49, 50-64, and 65-85 years) and explore whether age differences in chemotherapy matched survival gains in patients with GC. METHODS: Patients who were histologically diagnosed with GC were included from a Chinese multi-institutional database and the Surveillance, Epidemiology, and End Results database. There were 5,122 and 31,363 patients aged 18-85 years treated between 2000 and 2014, respectively. Overall survival and stage-specific likelihood of receiving chemotherapy were evaluated. RESULTS: Of the 5,122 and 31,363 patients in China and Surveillance, Epidemiology, and End Result data sets, 3,489 (68.1%) and 18,115 (57.8%) were men, respectively. Younger (18-49 years) and middle-aged (50-64 years) patients were more likely to receive chemotherapy compared with older patients (65-85 years) (64.9%, 56.7%, and 45.4% in the 3 groups from the China data set). Among patients treated with surgery alone, a significantly better prognosis was found in younger and middle-aged patients than their older counterparts; however, no significant differences were found in overall survival among age subgroups in patients who received both surgery and chemotherapy, especially in the China data set. The survival benefit from chemotherapy was superior among older patients (all P < 0.0001) compared with that among younger and middle-aged patients in stage II and III disease. DISCUSSION: Potential overuse of chemotherapy was found in younger and middle-aged patients with GC, but the addition of chemotherapy did not bring about matched survival improvement, especially in the China data set.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.14309/ctg.0000000000000253

Cites

53 of 53 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Overall survival of patients with gastric cancer by age category stratified by tumor stage at diagnosis in China and SEER data sets. China data set (left pane): (a) stage I (n = 936); (b) stage II (n = 1,087); (c) stage III (n = 2,558); and (d) stage IV (n = 541). SEER data set (right pane): (a) stage I (n = 8,071); (b) stage II (n = 3,914); (c) stage III (n = 4,666); and (d) stage IV (n = 2,591). SEER, Surveillance, Epidemiology, and End Result.
Figure 1. Overall survival of patients with gastric cancer by age category stratified by tumor stage at diagnosis in China and SEER data sets. China data set (left pane): (a) stage I (n = 936); (b) stage II (n = 1,087); (c) stage III (n = 2,558); and (d) stage IV (n = 541). SEER data set (right pane): (a) stage I (n = 8,071); (b) stage II (n = 3,914); (c) stage III (n = 4,666); and (d) stage IV (n = 2,591). SEER, Surveillance, Epidemiology, and End Result.CC BY-NC-ND · PubMed Central
Figure 2. Kaplan-Meier survival curves for patients with stage II and III gastric cancer in different age groups in China and SEER data sets, which were stratified by the receipt of chemotherapy. China data set (left pane): (a) stage II. (b) stage III. SEER data set (right pane): (a) stage II. (b) stage III. CT, chemotherapy; dotted curves, not received chemotherapy; SEER, Surveillance, Epidemiology, and End Result; solid curves, received chemotherapy.
Figure 2. Kaplan-Meier survival curves for patients with stage II and III gastric cancer in different age groups in China and SEER data sets, which were stratified by the receipt of chemotherapy. China data set (left pane): (a) stage II. (b) stage III. SEER data set (right pane): (a) stage II. (b) stage III. CT, chemotherapy; dotted curves, not received chemotherapy; SEER, Surveillance, Epidemiology, and End Result; solid curves, received chemotherapy.CC BY-NC-ND · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 53 references

Cited by

See all 18

Metadata

Authors
Jiang, Y., Xie, J., Huang, W., Chen, H., Xi, S., Li, T., Chen, C., Sun, Z., Hu, Y., Liu, W., Yu, J., Zhou, Z., Cai, S., & Li, G.
Affiliations
  • Sun Yat-sen University (CN)
  • Nanfang Hospital (CN)
  • Sun Yat-sen University Cancer Center (CN)
Corresponding author
  • Li, Tuanjie
  • Zhou, Zhiwei
  • Cai, Shirong
  • Li, Guoxin
Venue
Clinical and Translational Gastroenterology
Published
2020-10
Volume
11
Issue
10
Pages
e00253
ISSN
2155-384X (ISSN-L)
OpenAlex
W3094499069
Cited by
18
References
53
Citations by year
2026: 1 · 2025: 6 · 2024: 4 · 2023: 4 · 2022: 2 · 2021: 1
FWCI
0.99
Type
journal article
Language
en
Open access
Locations
  • Clinical and Translational Gastroenterology (publishedVersion, cc-by-nc-nd)
  • Europe PMC (PubMed Central) (publishedVersion, other-oa)
  • PubMed Central (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
  • National Natural Science Foundation of China (81600510, 81872013, 81672446)
  • Natural Science Foundation of Guangdong Province
  • Southern Medical University
  • Nanfang Hospital
  • National Key Research and Development Program of China (2017YFC0108300)
Topics
  • Health Sciences › Medicine › Oncology › Gastric Cancer Management and Outcomes
  • Health Sciences › Medicine › Surgery › Intraperitoneal and Appendiceal Malignancies
  • Health Sciences › Medicine › Surgery › Esophageal Cancer Research and Treatment
Keywords
gastric cancer, chemotherapy use, age differences, overall survival, young and middle-aged patients, surgical treatment, stage-specific survival, SEER database, China
MeSH terms
Adolescent, Adult, Age Factors, Aged, Aged, 80 and over, Antineoplastic Agents, China, Female, Gastrectomy, Humans, Male, Middle Aged, Neoplasm Staging, Prognosis, Stomach Neoplasms, United States, Treatment Outcome, Chemotherapy, Adjuvant, SEER Program, Kaplan-Meier Estimate, Young Adult, Datasets as Topic

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer. https://app.cochat.ai/papers/10.14309/ctg.0000000000000253
The paper
Jiang, Y., Xie, J., Huang, W., Chen, H., Xi, S., Li, T., Chen, C., Sun, Z., Hu, Y., Liu, W., Yu, J., Zhou, Z., Cai, S., & Li, G. (2020). Chemotherapy Use and Survival Among Young and Middle-Aged Patients With Gastric Cancer. Clinical and Translational Gastroenterology. https://doi.org/10.14309/ctg.0000000000000253

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.